Topic
History of Smallpox Eradication
In 1980, the World Health Assembly declared smallpox eradicated. A disease that had killed and scarred generations had ceased to circulate naturally. The achievement joined vaccination to an international effort to find outbreaks, interrupt transmission, and verify that no cases remained.
The decisive campaign was a history of reliable vaccines, field investigation, political cooperation, and local labour. Its final years also reveal the tensions between urgent disease control and the people subjected to it.
Before the global campaign
Vaccination made prevention possible
Smallpox, caused by variola virus, brought fever and a characteristic eruption of skin lesions. Survivors could be left with deep scars or blindness. Its history included both severe variola major and the much less lethal variola minor; differences in severity mattered when recognising the final outbreaks. Eradication meant ending transmission worldwide, a more demanding goal than eliminating the disease within one country. [1]
Before vaccination, practitioners in parts of Asia and Africa used variolation: deliberately introducing material from smallpox lesions into someone who had not had the disease. It could confer protection but could also cause fatal illness and spread infection. In 1796, Edward Jenner tested protection using material from a cowpox lesion; his published work helped vaccination spread. The later eradication vaccine used vaccinia, a related virus, rather than variola. [2]
The availability of a vaccine did not make eradication immediate. Reliable supply, trained workers, public participation, and sustained administration were all necessary. As the wider history of vaccination shows, a preventive technique and a functioning vaccination programme are different achievements. Countries that stopped local transmission could still face imported infections while smallpox circulated elsewhere. [2]
1958–1967
A global ambition gained an international programme
In 1958, Soviet virologist and deputy health minister Viktor Zhdanov urged the World Health Assembly to pursue worldwide eradication. The proposal helped turn smallpox from a collection of national problems into a shared international objective. The WHO programme began in 1959, but shortages of money, staff, and vaccine, together with uneven political commitment, limited progress. [3] [2]
The intensified programme launched in 1967 brought stronger coordination. Donald A. Henderson led the WHO smallpox unit during much of the decisive period. Cooperation crossed Cold War divisions: national governments, vaccine producers, international advisers, and local health services contributed different parts of the work. In his later recollections, Henderson stressed how poor vaccine quality had undermined earlier campaigns. Counting injections could not establish that people had actually been protected. [3]
WHO helped coordinate standards and international support, but national personnel carried out much of the vaccination and searching. The campaign depended on people who could reach households, recognise possible cases, and connect local reports to an organised response. Its international character rested on this daily work as well as on agreements between governments. [4]
Vaccine and delivery
Small practical improvements supported work at scale
Freeze-dried vaccine made supplies more dependable under demanding transport and storage conditions. Vaccine used in the campaign commonly came from vaccinia grown on animal skin; production and testing standards therefore mattered alongside preservation. WHO adopted smallpox vaccine quality recommendations in 1959 and revised them in 1965. The vaccine was an industrial and regulatory product as well as a medical discovery. [5]
The bifurcated needle, developed in 1961, offered a simple delivery tool with two prongs that held a small amount of vaccine. Compared with earlier methods, it used less vaccine and simplified training. These advantages helped workers extend coverage, although an efficient instrument could not substitute for potent supplies or careful organisation. [6]
Finding each outbreak
Surveillance and containment changed the measure of success
Early programmes emphasised mass vaccination, often aiming to reach at least 80 per cent of a population. Such coverage could greatly reduce disease but still leave susceptible groups and continuing outbreaks. Surveillance and containment directed attention to where transmission was actually occurring. Teams sought cases, traced contacts, and vaccinated people around an outbreak, an approach commonly called ring vaccination. [6]
This was not vaccination replaced by observation. Case-finding made vaccination more targeted, while containment required rapid action around infected people. Reports had to reach teams capable of investigating them; a suspected case in a remote village was useful information only if someone could get there. WHO photographs and programme accounts record workers travelling on foot and adapting transport to difficult terrain. [7]
Smallpox spread through human chains of infection, with no natural animal reservoir sustaining the disease. Breaking those chains could therefore bring transmission to an end. Nevertheless, visible illness did not guarantee correct diagnosis or reporting. The campaign made epidemiology a practical activity of searching, recording, checking, and responding, rather than simply compiling totals after an epidemic. [7] [3]
The final campaigns
Progress depended on local institutions and public cooperation
Endemic smallpox disappeared from South America in 1971, Asia in 1975, and Africa in 1977. These milestones conceal uneven progress. India faced a severe epidemic in 1974 even as eradication work intensified. Searches, additional resources, and stronger coordination helped interrupt the remaining transmission; the last indigenous Indian case occurred in May 1975. [4] [8]
Historical research on India shows that relations between central authorities, state administrations, and international staff shaped what could be done. An instruction from headquarters did not automatically produce effective work in a district. The achievement required negotiations over responsibility and resources as well as trained teams able to keep operating in difficult conditions. [9]
The campaign also raises questions about medical authority. A study of its final South Asian stages documents intimidation, coercion, and resistance. Measures used to secure immediate containment could produce resentment among residents and health workers. Ending a devastating disease was an extraordinary benefit, but that outcome does not remove the need to examine how people were treated. Cooperation and compulsion both belong in the history. [10]
1975–1978
The last natural case was not the last laboratory-associated outbreak
In 1975, Rahima Banu, a young child in Bangladesh, became the last known person with naturally acquired variola major. In October 1977, Ali Maow Maalin, a hospital cook in Somalia, developed variola minor and became the last known naturally infected smallpox patient. He recovered. These were distinct milestones: the end of the more severe form preceded the end of all natural transmission. [2]
In 1978, a laboratory-associated outbreak in Birmingham, England, demonstrated that stopping natural transmission had not removed every danger. Medical photographer Janet Parker died of smallpox; another infection occurred in her mother. The episode made laboratory containment central to the final assessment of eradication. It must be distinguished from the naturally circulating disease whose last chain had ended in Somalia. [11] [2]
1979–1980
Eradication had to be demonstrated
An absence of reports could mean that smallpox had disappeared, or that surveillance had failed to find it. International certification therefore required evidence about searches, reporting systems, and investigation of suspected cases. Countries where smallpox had recently circulated, and others at particular risk of importation, were assessed by international commissions. The task was to establish confidence in the absence of transmission. [8]
The Global Commission certified worldwide eradication in December 1979. On 8 May 1980, the World Health Assembly formally declared the world free of smallpox. The distinction between the 1977 natural case, the 1979 certification, and the 1980 declaration explains why several dates appear in accounts of the achievement. Each marks a different stage: transmission ending, evidence being judged, and the international declaration. [1] [12]
After eradication
Success created a new set of responsibilities
After the 1980 declaration, WHO organised a five-year programme to implement post-eradication policies. These included ending routine smallpox vaccination except for researchers at special risk, maintaining an emergency vaccine reserve, investigating suspected cases, supervising remaining virus stocks, and preserving records of the campaign. Eradication changed the purpose of international work from interrupting everyday transmission to protecting and documenting what had been achieved. [13]
The medical significance reaches beyond a single vaccine. Smallpox eradication joined prevention to dependable manufacture, local case-finding, targeted intervention, and independent verification. Its history also shows why accounts centred on a few celebrated leaders are incomplete: laboratory staff, vaccinators, administrators, families, and people who reported illness all helped make the result possible. The achievement belongs within the broader history of public health, including its questions about evidence, responsibility, and trust. [7] [9]
References
Sources and further reading
-
World Health Organization, “Smallpox”
Disease overview and the international certification milestone. Read the source.
-
US Centers for Disease Control and Prevention, “History of Smallpox”
Early prevention, the global programme, and the final patients; distinguishes variola major, variola minor, and laboratory-associated infection. Read the source.
-
“Lessons from the eradication of smallpox: an interview with D. A. Henderson” (2013)
A programme leader’s retrospective account, useful as participant testimony rather than a complete account of every country’s experience. Read the source.
-
World Health Organization, “History of smallpox vaccination”
International cooperation and regional milestones in the vaccination campaign. Read the source.
-
World Health Organization, “Smallpox” vaccine standards
Vaccine production and the development of quality recommendations. Read the source.
-
World Health Organization, “Smallpox vaccines” (2016)
Mass vaccination, ring vaccination, and the bifurcated needle. Read the source.
-
World Health Organization, “Smallpox Eradication Programme (1966–1980)”
An institutional photographic account of surveillance, prevention, and field conditions. Read the source.
-
World Health Organization, The Global Eradication of Smallpox: Final Report of the Global Commission for the Certification of Smallpox Eradication (1980)
The official assessment of programme results and the evidence supporting certification. Read the source.
-
Sanjoy Bhattacharya, “Uncertain Advances: A Review of the Final Phases of the Smallpox Eradication Program in India, 1960–1980” (2004)
Historical research on administrative relationships and the uneven implementation of eradication in India. Read the source.
-
“Intimidation, coercion and resistance in the final stages of the South Asian Smallpox Eradication Campaign, 1973–1975” (1995)
A study of coercive practices and their contested consequences during the final campaigns. Read the source.
-
World Health Organization, “Smallpox” questions and answers
Distinguishes the end of natural transmission from the 1978 laboratory accident. Read the source.
-
World Health Organization, “World Health Assembly resolutions and reports”
Official record linking the 8 May 1980 declaration, WHA33.3, and subsequent policy resolutions. Read the source.
-
World Health Organization, “Post-eradication” (2016)
The responsibilities adopted after 1980, including surveillance, vaccine reserves, laboratory safety, and documentation. Read the source.
Related Reading
Where to go next
Explore the history of vaccination, Edward Jenner, and the World Health Organization. For the wider development of field investigation and prevention, continue with the history of epidemiology and the history of public health.